Literature DB >> 27931610

Biological Phenotyping of Combined Post-Capillary and Pre-Capillary Pulmonary Hypertension: Focus on Pulmonary Vascular Remodeling.

Jane A Leopold1.   

Abstract

Entities:  

Keywords:  combined pulmonary hypertension; pulmonary arterial hypertension; whole exome sequencing

Mesh：

Year:  2016        PMID： 27931610      PMCID： PMC5508208          DOI： 10.1016/j.jacc.2016.10.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

1.  Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease.

Authors:  Yingjie Chen; Haipeng Guo; Dachun Xu; Xin Xu; Huan Wang; Xinli Hu; Zhongbing Lu; Dongmin Kwak; Yawei Xu; Roland Gunther; Yuqing Huo; E Kenneth Weir
Journal:  Hypertension       Date:  2012-04-16       Impact factor: 10.190

2.  Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.

Authors:  Mario Gerges; Christian Gerges; Anna-Maria Pistritto; Marie B Lang; Pia Trip; Johannes Jakowitsch; Thomas Binder; Irene M Lang
Journal:  Am J Respir Crit Care Med       Date:  2015-11-15       Impact factor: 21.405

3.  The right heart and pulmonary circulation (III). The pulmonary circulation in heart failure.

Authors:  Juan F Delgado
Journal:  Rev Esp Cardiol       Date:  2010-03       Impact factor: 4.753

4.  Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

Authors:  Christian F Opitz; Marius M Hoeper; J Simon R Gibbs; Harald Kaemmerer; Joanna Pepke-Zaba; J Gerry Coghlan; Laura Scelsi; Michele D'Alto; Karen M Olsson; Silvia Ulrich; Werner Scholtz; Uwe Schulz; Ekkehard Grünig; Carmine D Vizza; Gerd Staehler; Leonhard Bruch; Doerte Huscher; David Pittrow; Stephan Rosenkranz
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

5.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

6.  Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure.

Authors:  Wayne L Miller; Diane E Grill; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2013-08-05       Impact factor: 12.035

Review 7.  Left ventricular heart failure and pulmonary hypertension.

Authors:  Stephan Rosenkranz; J Simon R Gibbs; Rolf Wachter; Teresa De Marco; Anton Vonk-Noordegraaf; Jean-Luc Vachiéry
Journal:  Eur Heart J       Date:  2015-10-27       Impact factor: 29.983
  7 in total
  7 in total

1.  Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Authors:  Jason M Elinoff; Richa Agarwal; Christopher F Barnett; Raymond L Benza; Michael J Cuttica; Ahmed M Gharib; Michael P Gray; Paul M Hassoun; Anna R Hemnes; Marc Humbert; Todd M Kolb; Tim Lahm; Jane A Leopold; Stephen C Mathai; Vallerie V McLaughlin; Ioana R Preston; Erika B Rosenzweig; Oksana A Shlobin; Virginia D Steen; Roham T Zamanian; Michael A Solomon
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

2.  Pulmonary Hypertension Subtypes and Mortality in CKD.

Authors:  Daniel L Edmonston; Kishan S Parikh; Sudarshan Rajagopal; Linda K Shaw; Dennis Abraham; Alexander Grabner; Matthew A Sparks; Myles Wolf
Journal:  Am J Kidney Dis       Date:  2019-11-12       Impact factor: 8.860

Review 3.  Combined pre- and post-capillary pulmonary hypertension in left heart disease.

Authors:  M Riccardi; M Pagnesi; E Sciatti; C M Lombardi; R M Inciardi; M Metra; E Vizzardi
Journal:  Heart Fail Rev       Date:  2022-06-01       Impact factor: 4.214

Review 4.  Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.

Authors:  Andrea R Levine; Marc A Simon; Mark T Gladwin
Journal:  Trends Cardiovasc Med       Date:  2018-08-17       Impact factor: 6.677

Review 5.  The Biological Bases of Group 2 Pulmonary Hypertension.

Authors:  Ana I Fernández; Raquel Yotti; Ana González-Mansilla; Teresa Mombiela; Enrique Gutiérrez-Ibanes; Candelas Pérez Del Villar; Paula Navas-Tejedor; Christian Chazo; Pablo Martínez-Legazpi; Francisco Fernández-Avilés; Javier Bermejo
Journal:  Int J Mol Sci       Date:  2019-11-23       Impact factor: 5.923

6.  Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure.

Authors:  Wande Yu; Xie Dujiang; Wang Yi; Ding Guanwen; Zhang Mengyu; Pan Chang; Zhang Aikai; Zhang Juan; Zhu Linlin; Zhang Hang
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

7.  Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI.

Authors:  Christopher S Johns; James M Wild; Smitha Rajaram; Euan Tubman; David Capener; Charlie Elliot; Robin Condliffe; Athanasios Charalampopoulos; David G Kiely; Andrew J Swift
Journal:  Radiology       Date:  2018-07-03       Impact factor: 29.146
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.